No changes in fields
Text
What is the preferred initial management for symptomatic patients with hypertrophic obstructive cardiomyopathy?
- First-line: {{c1::β-blockers}}
- Second-line: {{c1::Non-dihydropyridine Ca2+ channel blockers}}
- First-line: {{c1::β-blockers}}
- Second-line: {{c1::Non-dihydropyridine Ca2+ channel blockers}}
Extra
- However, dihydropyridine CCBs are contraindicated
- Verapamil or disopyramide can be used as additional therapy in patients with persistent symptoms; these ↓ HR and therefore prolong diastolic filling thus decreasing outflow obstruction

- Verapamil or disopyramide can be used as additional therapy in patients with persistent symptoms; these ↓ HR and therefore prolong diastolic filling thus decreasing outflow obstruction

Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy 2





Watch Hypertrophic Cardiomyopathy SOAP





Watch Hypertrophic Cardiomyopathy SOAP
Sketchy Extra
Empty field
Picmonic
Empty field
Physeo
Empty field
Bootcamp
Empty field
OME
Additional Resources
One by one
Empty field














